MedTech Dive November 21, 2022
Nick Paul Taylor

Dive Brief:

  • H2o Therapeutics has received 510(k) clearance for an Apple Watch app that monitors Parkinson’s disease symptoms such as tremors and dyskinesia.
  • The smartwatch app uses Apple’s movement disorder API and the inertial sensors of the device to provide insights into patients’ symptoms between visits to their clinicians.
  • Apple validated the technology in a clinical trial, positioning h2o to create an app that enables the sharing of objective Parkinson’s symptom data between patients and medical professionals.

Dive Insight:

Apple laid the foundation for the app last year by publishing the results of a clinical trial of 343 people with Parkinson’s disease. The tech company ran the study to evaluate its Motor fluctuations Monitor for Parkinson’s Disease (MM4PD)...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Apps, Digital Health, FDA, Govt Agencies, Technology, Wearables
Related Articles:
Wearable Tech Revolutionizes Remote Patient Monitoring
Smart patch combines real-time health monitoring and drug delivery
Advanced wearable technology improves support for people with dementia and their caregivers
The future of cardiac monitoring: AI-powered wearables in practice
Continuous Glucose Monitors Predict Type 1 Diabetes Complications

Share This Article